Skip to main content
Article
ACTR-33. A PHASE I DOSE ESCALATION AND CENTRAL NERVOUS SYSTEM (CNS) PHARMACOKINETIC STUDY OF PULSATILE AFATINIB IN PATIENTS WITH BRAIN CANCER
Neuro-oncology (2017)
  • Tiffany Juarez, John Wayne Cancer Institute at Providence Saint John’s Health Center, Santa Monica, CA, USA
  • Najee Boucher, John Wayne Cancer Institute at Providence Saint John’s Health Center, Santa Monica, CA, USA
  • Annie Heng, John Wayne Cancer Institute at Providence Saint John’s Health Center, Santa Monica, CA, USA
  • Jaya Gill, John Wayne Cancer Institute at Providence Saint John’s Health Center, Santa Monica, CA, USA
  • Minhdan Nguyen, John Wayne Cancer Institute at Providence Saint John’s Health Center, Santa Monica, CA, USA
  • Judy Truong, John Wayne Cancer Institute at Providence Saint John’s Health Center, Santa Monica, CA, USA
  • Marlon Saria, John Wayne Cancer Institute at Providence Saint John’s Health Center, Santa Monica, CA, USA
  • Achal Achrol, John Wayne Cancer Institute at Providence Saint John’s Health Center, Santa Monica, CA, USA
  • Garni Barkhoudarian, John Wayne Cancer Institute at Providence Saint John’s Health Center, Santa Monica, CA, USA
  • Daniel Kelly, John Wayne Cancer Institute at Providence Saint John’s Health Center, Santa Monica, CA, USA
  • Santosh Kesari, John Wayne Cancer Institute at Providence Saint John’s Health Center, Santa Monica, CA, USA
Publication Date
November 6, 2017
DOI
10.1093/neuonc/nox168.026
Citation Information
Tiffany Juarez, Najee Boucher, Annie Heng, Jaya Gill, et al.. "ACTR-33. A PHASE I DOSE ESCALATION AND CENTRAL NERVOUS SYSTEM (CNS) PHARMACOKINETIC STUDY OF PULSATILE AFATINIB IN PATIENTS WITH BRAIN CANCER" Neuro-oncology Vol. 19 (2017)
Available at: http://works.bepress.com/marlon-saria/11/